Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MAX: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
MAX is a gene implicated in neurodegeneration research. Key relationships include: associated with, regulates, inhibits. Associated with ALS, Aging, Als. Connected to 154 entities in the SciDEX knowledge graph.
| Gene Symbol | MAX |
| Full Name | MYC-associated factor X |
| Chromosome | 14q23.3 |
| Protein Family | bHLH-LZ Transcription Factor Family |
| Protein Type | Transcription Factor |
| Function | MYC-MAX heterodimers activate target genes |
| Subcellular Localization | Nuclear |
| Molecular Weight | ~18 kDa |
| Amino Acids | 160 aa |
| Pathways | Tgf-Β |
| UniProt ID | P61275 |
| GeneCards | MAX |
| Human Protein Atlas | MAX |
| Protein Length | 160 amino acids |
| Protein Class | bHLH-LZ transcription factor |
| Associated Diseases | ALS, Aging, Autoimmune, Cancer, Ms |
| Interactions | CGAS, STING, PARP1, IRF3, EMD, MYC |
| KG Connections | 216 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
MAX["MAX<br/>Transcription Factor"]
CGAS["cGAS<br/>DNA Sensor"]
STING["STING<br/>Innate Immunity"]
PARP1["PARP1<br/>DNA Repair"]
Neurodegeneration["Neurodegeneration<br/>Progressive Loss"]
ALS["Amyotrophic Lateral<br/>Sclerosis (ALS)"]
MS["Multiple Sclerosis<br/>(MS)"]
Parkinsons["Parkinson's<br/>Disease"]
Aging["Cellular<br/>Aging"]
Autoimmune["Autoimmune<br/>Response"]
Cancer["Cancer<br/>Development"]
Tumor["Tumor<br/>Formation"]
Inflammation["Chronic<br/>Inflammation"]
DNA_Damage["DNA Damage<br/>Response"]
Cell_Death["Neuronal<br/>Cell Death"]
Therapeutic["Therapeutic<br/>Target"]
MAX --|"inhibits"|--> CGAS
MAX --|"inhibits"|--> STING
MAX --|"inhibits"|--> PARP1
CGAS --|"activates"|--> STING
STING --|"promotes"|--> Inflammation
PARP1 --|"responds to"|--> DNA_Damage
MAX --|"regulates"|--> Aging
MAX --|"associated with"|--> Neurodegeneration
MAX --|"activates"|--> ALS
MAX --|"activates"|--> MS
MAX --|"associated with"|--> Parkinsons
Inflammation --|"contributes to"|--> Neurodegeneration
DNA_Damage --|"leads to"|--> Cell_Death
Aging --|"promotes"|--> Neurodegeneration
MAX --|"activates"|--> Autoimmune
Autoimmune --|"triggers"|--> MS
MAX --|"therapeutic target"|--> Therapeutic
style MAX fill:#006494
style PARP1 fill:#4a1a6b
style CGAS fill:#4a1a6b
style STING fill:#4a1a6b
style Therapeutic fill:#1b5e20
style Neurodegeneration fill:#5d4400
style ALS fill:#ef5350
style MS fill:#ef5350
style Parkinsons fill:#ef5350
style Inflammation fill:#ef5350
style Cell_Death fill:#ef5350
style Autoimmune fill:#ef5350
style Cancer fill:#ef5350
style Aging fill:#5d4400| Target | Relation | Type | Str |
|---|---|---|---|
| Cancer | inhibits | disease | 0.85 |
| Tumor | inhibits | disease | 0.85 |
| Neurodegeneration | therapeutic_target | disease | 0.75 |
| Aging | therapeutic_target | disease | 0.75 |
| Als | therapeutic_target | disease | 0.75 |
| Als | associated_with | disease | 0.75 |
| Als | inhibits | disease | 0.75 |
| MYC | interacts_with | gene | 0.70 |
| MYC | inhibits | gene | 0.70 |
| Myelodysplastic Syndrome | inhibits | disease | 0.65 |
| Encephalitis | activates | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Aging | regulates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Multiple Sclerosis | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Autoimmune | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Cancer | expressed_in | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Autoimmune | associated_with | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Multiple Sclerosis | associated_with | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| ALS | expressed_in | disease | 0.65 |
| Neuroblastoma | therapeutic_target | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Lymphoma | therapeutic_target | disease | 0.65 |
| Leukemia | inhibits | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | therapeutic_target | disease | 0.65 |
| Depression | activates | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Depression | transports | disease | 0.65 |
| ALS | inhibits | disease | 0.65 |
| CGAS | inhibits | gene | 0.60 |
| STING | inhibits | gene | 0.60 |
| PARP1 | inhibits | gene | 0.60 |
| IRF3 | inhibits | gene | 0.60 |
| MIRO1 | regulates | gene | 0.60 |
| MID51 | regulates | gene | 0.60 |
| MID49 | regulates | gene | 0.60 |
| MFF | regulates | gene | 0.60 |
| EMD | activates | gene | 0.60 |
| EGFR | regulates | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| CANCER | inhibits | gene | 0.80 |
| DRP1 | regulates | gene | 0.60 |
| TOMM20 | regulates | gene | 0.60 |
| AQP4 | activates | gene | 0.60 |
| APP | regulates | gene | 0.60 |
| ST6GAL1 | regulates | gene | 0.60 |
| PLA2G6 | therapeutic_target | gene | 0.60 |
| PANK2 | therapeutic_target | gene | 0.60 |
| STING | inhibits | gene | 0.60 |
| CGAS | inhibits | gene | 0.60 |
| MFF | regulates | gene | 0.60 |
| EMD | activates | gene | 0.60 |
| BACE1 | regulates | gene | 0.60 |
| CGAS | activates | gene | 0.60 |
| IRF3 | activates | gene | 0.60 |
| AQP4 | associated_with | gene | 0.60 |
| EMD | associated_with | gene | 0.60 |
| APP | associated_with | gene | 0.60 |
| BACE1 | associated_with | gene | 0.60 |
| EGFR | associated_with | gene | 0.60 |
| FUT8 | associated_with | gene | 0.60 |
| PARP1 | inhibits | gene | 0.60 |
| IRF3 | inhibits | gene | 0.60 |
| MID51 | regulates | gene | 0.60 |
| MID49 | regulates | gene | 0.60 |
| MIRO1 | regulates | gene | 0.60 |
| FUT8 | regulates | gene | 0.60 |
| EGFR | regulates | gene | 0.60 |
| OVERVIEW | expressed_in | gene | 0.60 |
| GAIN | therapeutic_target | gene | 0.60 |
| FUS | therapeutic_target | gene | 0.60 |
| MTOR | associated_with | gene | 0.60 |
| GFAP | inhibits | gene | 0.60 |
| MTDNA | expressed_in | gene | 0.60 |
| ERBB3 | associated_with | gene | 0.60 |
| AGING | associated_with | gene | 0.60 |
| DNA | inhibits | gene | 0.60 |
| IFN | inhibits | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | regulates | gene | 0.60 |
| AQUAPORIN-4 | activates | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| ERBB3 | regulates | gene | 0.60 |
| TCR | regulates | gene | 0.60 |
| PARKINSON'S DISEASE | degrades | gene | 0.60 |
| PARKINSON | associated_with | gene | 0.60 |
| NEURODEGENERATION | associated_with | gene | 0.60 |
| MITOCHONDRIAL DNA | expressed_in | gene | 0.60 |
| DNA | expressed_in | gene | 0.60 |
| MITOCHONDRIA | expressed_in | gene | 0.60 |
| CANCER | expressed_in | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
research methodology | 2026-04-11 | 0 hypotheses
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||